1. Home
  2. STGW vs AMPH Comparison

STGW vs AMPH Comparison

Compare STGW & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stagwell Inc.

STGW

Stagwell Inc.

HOLD

Current Price

$6.15

Market Cap

1.4B

Sector

N/A

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$19.05

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STGW
AMPH
Founded
1980
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2006
2005

Fundamental Metrics

Financial Performance
Metric
STGW
AMPH
Price
$6.15
$19.05
Analyst Decision
Strong Buy
Buy
Analyst Count
7
7
Target Price
$8.39
$30.29
AVG Volume (30 Days)
1.8M
581.3K
Earning Date
03-10-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.03
Revenue
$2,909,000,000.00
$719,887,000.00
Revenue This Year
$14.09
$7.34
Revenue Next Year
$2.59
$4.81
P/E Ratio
N/A
$9.36
Revenue Growth
2.39
N/A
52 Week Low
$4.03
$17.03
52 Week High
$7.17
$31.26

Technical Indicators

Market Signals
Indicator
STGW
AMPH
Relative Strength Index (RSI) 65.29 32.55
Support Level $4.94 N/A
Resistance Level $6.50 $28.56
Average True Range (ATR) 0.33 1.09
MACD 0.13 -0.09
Stochastic Oscillator 82.17 32.08

Price Performance

Historical Comparison
STGW
AMPH

About STGW Stagwell Inc.

Stagwell Inc is the challenger holding company built to transform marketing. It delivers scaled creative performance for the world's ambitious brands, connecting culture-moving creativity with a technology to harmonize the art and science of marketing. The company's segments include Integrated Agencies Network; Brand Performance Network; and Communications Network. It generates maximum revenue from the Integrated Agencies Network segment. Geographically, it derives a majority of its revenue from the United States.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: